BNC KOREA, Inc. (KOSDAQ:256840)
2,840.00
-100.00 (-3.40%)
Jun 10, 2026, 3:30 PM KST
BNC KOREA Revenue
BNC KOREA had revenue of 20.73B KRW in the quarter ending March 31, 2026, a decrease of -18.45%. This brings the company's revenue in the last twelve months to 91.21B, down -6.38% year-over-year. In the year 2025, BNC KOREA had annual revenue of 95.90B with 7.47% growth.
Revenue (ttm)
91.21B
Revenue Growth
-6.38%
P/S Ratio
2.13
Revenue / Employee
364.84M
Employees
250
Market Cap
194.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 95.90B | 6.67B | 7.47% |
| Dec 31, 2024 | 89.23B | 8.23B | 10.16% |
| Dec 31, 2023 | 81.00B | 38.69B | 91.47% |
| Dec 31, 2022 | 42.30B | 17.05B | 67.55% |
| Dec 31, 2021 | 25.25B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 952.66B |
| Suheung | 743.02B |
| Daewon Pharmaceutical | 605.66B |
| Samjin Pharmaceuticals | 274.03B |
| Whan In Pharm | 266.19B |
| JW Lifescience | 252.72B |
| Boditech Med | 165.84B |
| Yungjin Pharm. | 158.79B |